Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IMMUNOCORE HOLDINGS PLC

(IMCR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Immunocore : Jefferies Starts Immunocore Holdings at Buy With $65 Price Target

03/02/2021 | 08:05am EST


ę MT Newswires 2021
All news about IMMUNOCORE HOLDINGS PLC
11/11Immunocore to present at the Jefferies London Healthcare Conference
GL
11/10Immunocore Posts Narrower Q3 Loss, Lower Revenue
MT
11/10INDEX TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K
PU
11/10Corporate Presentation - November 2021
PU
11/10Immunocore Reports Third Quarter 2021 Financial Results and Provides Business Update
GL
11/10Immunocore Holdings plc Reports Earnings Results for the Third Quarter and Nine Months ..
CI
11/09Immunocore presents new data on tebentafusp in metastatic cutaneous melanoma (mCM) and ..
AQ
11/09Immunocore Holdings plc Presents New Data on Tebentafusp in Metastatic Cutaneous Melano..
CI
10/18IMMUNOCORE : to Collaborate With Medison Pharma to Expand Reach of Metastatic Uveal Melano..
MT
10/18IMMUNOCORE : and Medison Pharma Partner for Future Commercialization of Tebentafusp in Can..
GL
More news
Analyst Recommendations on IMMUNOCORE HOLDINGS PLC
More recommendations
Financials
Sales 2021 26,5 M 35,2 M 35,2 M
Net income 2021 -126 M -167 M -167 M
Net cash 2021 163 M 217 M 217 M
P/E ratio 2021 -8,15x
Yield 2021 -
Capitalization 1 060 M 1 409 M 1 408 M
EV / Sales 2021 33,8x
EV / Sales 2022 29,4x
Nbr of Employees 291
Free-Float 73,4%
Chart IMMUNOCORE HOLDINGS PLC
Duration : Period :
Immunocore Holdings plc Technical Analysis Chart | IMCR | US45258D1054 | MarketScreener
Technical analysis trends IMMUNOCORE HOLDINGS PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 2 416,72 GBX
Average target price 3 947,03 GBX
Spread / Average Target 63,3%
EPS Revisions
Managers and Directors
Bahija Jallal Chief Executive Officer & Director
Brian R. DiDonato Chief Financial Officer & Head-Strategy
David Berman Head-Research & Development
Roy Steven Herbst Non-Executive Director
John Irving Bell Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
IMMUNOCORE HOLDINGS PLC0.00%1 409
MODERNA, INC.197.32%125 937
LONZA GROUP AG28.34%58 955
IQVIA HOLDINGS INC.44.70%49 527
SEAGEN INC.-9.64%28 937
CELLTRION, INC.-40.67%24 625